August 21, 2017 9:17 PM ET


Company Overview of Five Prime Therapeutics, Inc.

Executive Profile

Lewis L. Lanier Ph.D.

Member of Scientific Advisory Board, Five Prime Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships


Prof. Lewis L. Lanier, Ph.D. has been Professor of Department of Microbiology & Immunology and Cancer Research Institute at University of California, San Francisco since 1999 and has been Vice Chair of Department of Microbiology & Immunology since 2003. Prof. Lanier serves as Head of the UCSF Immunology Program and Program Leader of the UCSF Comprehensive Cancer Center. He was a Senior Research Scientist at Becton Dickinson Monoclonal Center, Inc. from 1981 to 1988. ...

Corporate Headquarters

Two Corporate Drive
South San Francisco, California 94080

United States

Phone: 415-365-5600
Fax: 415-365-5601

Board Members Memberships

There is no Board Members Memberships data available.


BS 1975
Virginia Polytechnic Institute and State University
PhD 1981
University of New Mexico
PhD 1979
University of North Carolina

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Five Prime Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at